Although inconsistently reported (25), unusually prolonged, severe, and life-threatening infections with common bacterial pathogens are being seen in children with JIA treated with combined DMARDs, including anti–TNF-α agents (26,27). The gene discussed is TNF; the disease is juvenile idiopathic arthritis.